The Valley Desk

Clinical trial reportJournal of clinical oncology : official journal of the American Society of Clinical OncologyPublished

PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-Negative Metastatic Breast Cancer

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published
Subject terms
Humans; Breast Neoplasms; Disease Progression; Piperazines; Pyridines; Receptors, Estrogen; Receptors, Progesterone; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Protein Kinase Inhibitors; Adult; Aged
PubMed ID
38513188
Added to directory
Source checked

Report a correction or request removal